Patent Attorney Attends International Polymer Colloids Group Conference

James Taylor, an attorney in our Livonia office, recently attended The International Polymer Colloids Group (IPCG) Conference in Ontario, Canada. The conference is held every two years and aims to bring together the world’s leading researchers from both academia and industry to exchange the latest developments in the area of polymer colloids science, as well as discuss new directions and future challenges. Polymer colloid science is of particular interest to […]

Read More

Attorney James Taylor Offers Insight and Analysis on Intellectual Property Case

Rapper Cardi B recently defeated a tort and intellectual property lawsuit for misappropriation of likeness and invasion of privacy for using a picture of a heavily tattooed man, without his permission, as the subject of her album cover picture. The creator of the album cover skewed and altered an innocent picture of Plaintiff Kevin Brophy, where he is simply showing off his tattoo, to create an entirely different scenario. Critically, […]

Read More

Religious ‘Hamilton’ Reproduction may be Legal in New Jersey but has caused a Controversy for a Texas Church

“Everything’s legal in New Jersey” is one of the more memorable lines from playwright Lin-Manuel Miranda’s ‘Hamilton’. But, unfortunately for a Texas church, they are not in New Jersey. The Door McAllen Church has been sued by the playwright for violating the Copyright Act when the church produced a modified version of Hamilton. Hamilton is Broadway play that depicts the founding of America through song and rap, using a diverse […]

Read More

The USPTO and FDA have Vowed to Help Generic Drug Manufacturers Enter the Marketplace

The patent system is designed as quid pro quo: inventors publicly explain how their inventions work, the government gives those inventors a limited monopoly, and then other manufacturers may compete.  However, Big pharma has been abusing the patenting system in order to try to bully generic drug manufacturers from entering the marketplace after their monopoly expires, causing excessive drug costs even after the initial patent expires for a drug.  Big […]

Read More

    CONTACT US

    I have read theDisclaimer

      CONTACT US

      I have read theDisclaimer